Baillie Gifford & CO Tandem Diabetes Care Inc Transaction History

Baillie Gifford & CO

$128 Billion
Q2 2025

A detailed history of Baillie Gifford & CO transactions in Tandem Diabetes Care Inc stock. As of the latest transaction made, Baillie Gifford & CO holds 1,125,728 shares of TNDM stock, worth $17.5 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

1,125,728

Previous 732,574 53.67%

Holding current value

$17.5 Million

Previous $14 Million 49.49%

% of portfolio

0.02%

Previous 0.01%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 06, 2025	BUY	$16.35 - $23.52 $6.43 Million - $9.25 Million	393,154 Added 53.67%	1,125,728 $21 Million
Q1 2025 May 07, 2025	SELL	$17.89 - $37.53 $242,141 - $507,968	-13,535 Reduced 1.81%	732,574 $14 Million
Q4 2024 Jan 31, 2025	BUY	$27.34 - $41.78 $14.3 Million - $21.9 Million	523,843 Added 235.68%	746,109 $26.9 Million
Q3 2024 Nov 05, 2024	SELL	$35.21 - $47.3 $4,225 - $5,676	-120 Reduced 0.05%	222,266 $9.42 Million
Q2 2024 Jul 25, 2024	SELL	$30.43 - $53.43 $1.14 Million - $1.99 Million	-37,311 Reduced 14.37%	222,386 $8.96 Million
Q1 2024 May 01, 2024	SELL	$22.09 - $35.41 $65,077 - $104,317	-2,946 Reduced 1.12%	259,697 $9.2 Million
Q4 2023 Jan 26, 2024	SELL	$14.28 - $31.03 $1,613 - $3,506	-113 Reduced 0.04%	262,643 $7.77 Million
Q2 2023 Jul 28, 2023	SELL	$24.18 - $42.46 $4,521 - $7,940	-187 Reduced 0.07%	262,756 $6.45 Million
Q1 2023 May 03, 2023	SELL	$35.86 - $46.5 $5,056 - $6,556	-141 Reduced 0.05%	262,943 $10.7 Million
Q3 2022 Oct 27, 2022	SELL	$43.76 - $68.97 $1.89 Million - $2.98 Million	-43,139 Reduced 14.09%	263,084 $12.6 Million
Q2 2022 Aug 08, 2022	SELL	$53.22 - $123.09 $1.47 Million - $3.39 Million	-27,578 Reduced 8.26%	306,223 $18.1 Million
Q1 2022 May 05, 2022	SELL	$101.89 - $150.09 $2.36 Million - $3.47 Million	-23,151 Reduced 6.49%	333,801 $38.8 Million
Q4 2021 Jan 20, 2022	BUY	$118.18 - $153.21 $1.17 Million - $1.52 Million	9,900 Added 2.85%	356,952 $53.7 Million
Q3 2021 Oct 19, 2021	BUY	$93.51 - $129.4 $11,875 - $16,433	127 Added 0.04%	347,052 $41.4 Million
Q2 2021 Aug 02, 2021	BUY	$77.0 - $100.19 $12,936 - $16,831	168 Added 0.05%	346,925 $33.8 Million
Q1 2021 May 06, 2021	BUY	$81.28 - $104.34 $4.17 Million - $5.35 Million	51,312 Added 17.37%	346,757 $30.6 Million
Q4 2020 Feb 10, 2021	BUY	$86.4 - $121.75 $15,206 - $21,428	176 Added 0.06%	295,445 $28.3 Million
Q2 2020 Aug 12, 2020	SELL	$60.05 - $98.92 $8.37 Million - $13.8 Million	-139,431 Reduced 32.08%	295,269 $29.2 Million
Q3 2018 Nov 13, 2018	BUY	$21.39 - $51.17 $9.3 Million - $22.2 Million	434,700 New	434,700 $18.6 Million

Others Institutions Holding TNDM

# of Institutions

299

Shares Held

79.8M

Call Options Held

2.87M

Put Options Held

134K

View Full List

About TANDEM DIABETES CARE INC

Ticker TNDM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 64,221,200
Market Cap $998M
Description
Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...

More about TNDM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Baillie Gifford & CO, based on Form 13F filings with the SEC.

News

Stay updated on Baillie Gifford & CO with notifications on news.

Account

Baillie Gifford & CO Tandem Diabetes Care Inc Transaction History